Israeli Pharmaceutical Company Donates 6 Million Doses of Chloroquine to US to treat Coronavirus

Israeli Pharmaceutical Company Teva is donating 6 million doses of chloroquine to the United States to treat the coronavirus.

President Trump called the news of chloroquine’s effectiveness in treating the COVID-19 virus a “game changer” this week.

This came after three international studies found chloroquine along with Azithromycin was successful in treating the coronavirus.

Teva is immediately donating 6 Million hydroxychloroquine sulfate tablets to US hospitals by March 31, with over 10 Million within a month to meet the urgent demand for the medicine as an investigational target to treat #COVID19.https://t.co/t4j8Olh324 pic.twitter.com/3U41DgzABd

— Teva Pharmaceuticals (@TevaUSA) March 20, 2020

The Washington Examiner reported:

Israel’s leading drug producer announced Thursday it will donate 6 million doses of anti-malaria drugs to the United States in hopes that it could be helpful treating coronavirus symptoms.

Advertisement - story continues below

Teva Pharmaceutical Industries says the drug could potentially treat people with the coronavirus and will ship the hydroxychloroquine tablets through wholesalers nationwide by the end of the month and will provide 10 million doses in total, according to Breitbart News.

“We are committed to helping to supply as many tablets as possible as demand for this treatment accelerates at no cost,” Teva Executive Vice President Brendan O’Grady said about the move.

President Trump has expressed support and optimism for potential treatments, including malaria drugs chloroquine and hydroxychloroquine.